Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             437 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 56 AAV Δ264CFTR enhances wt CFTR expression and maturation of ΔF508CFTR Cebotaru, L.
 2006
 5 S1 p. S13-
1 p.
 artikel
2 143 Ability of different strains of Pseudomonas aeruginosa (PA) to survive within artificially generated aerosols Clifton, I.J.
 2006
 5 S1 p. S32-
1 p.
 artikel
3 230 ABPA is not rare in CF patients under 6 years old: Epidemiological data in Greek CF patients for the period 1990–2005 Beri, D.
 2006
 5 S1 p. S54-
1 p.
 artikel
4 421 A CF kit for kindergarten Stroobants, A.
 2006
 5 S1 p. S94-
1 p.
 artikel
5 248 Acid stable amylolytic enzymes and lipase as components of pancreatic enzyme replacement in Cystic Fibrosis Scharpé, S.
 2006
 5 S1 p. S58-
1 p.
 artikel
6 347 A comparison of five airway clearance techniques in the treatment of people with Cystic Fibrosis Pryor, J.A.
 2006
 5 S1 p. S76-
1 p.
 artikel
7 408 A competency framework for nurses providing care and management of patients with Cystic Fibrosis Dyer, J.
 2006
 5 S1 p. S90-
1 p.
 artikel
8 370 Acute hypercapnic respiratory failure secondary to substance abuse in Cystic Fibrosis adults Gumery, L.
 2006
 5 S1 p. S82-
1 p.
 artikel
9 65 Acute respiratory infections in young CF children van Ewijk, B.
 2006
 5 S1 p. S15-
1 p.
 artikel
10 399 A descriptive survey designed to assess parents satisfaction with the Cystic Fibrosis annual review process at the Sheffield Children's NHS Trust Bott, S.
 2006
 5 S1 p. S88-
1 p.
 artikel
11 436 Adherence to airway clearance therapies in patients with Cystic Fibrosis Modi, A.C.
 2006
 5 S1 p. S97-
1 p.
 artikel
12 224 Adults with Cystic Fibrosis: a single centre experience over five years Hofer, M.
 2006
 5 S1 p. S52-
1 p.
 artikel
13 375 Aerobic and strength training in patients with Cystic Fibrosis (CF) and severe airway obstruction Donà, M.
 2006
 5 S1 p. S83-
1 p.
 artikel
14 184 Aerosolized tobramycin in the treatment of patients with Cystic Fibrosis and Pseudomonas aeruginosa infection Lenoir, G.
 2006
 5 S1 p. S42-
1 p.
 artikel
15 214 Airway reactivity in Cystic Fibrosis Ciofu, C.
 2006
 5 S1 p. S50-
1 p.
 artikel
16 36 A long-acting β2-adrenergic receptor agonist increases hydration and mucus exocytosis in human tracheal glandular cells Delavoie, E.
 2006
 5 S1 p. S8-
1 p.
 artikel
17 496 A longitudinal study of bone mineral density change in adults with Cystic Fibrosis Tomlinson, G.S.
 2006
 5 S1 p. S109-
1 p.
 artikel
18 104 A longitudinal study of the antimicrobial resistance of Pseudomonas aeruginosa in a Turkish CF Unit Torun, O.
 2006
 5 S1 p. S23-
1 p.
 artikel
19 39 Alpha-melanocyte stimulating hormone modulates respiratory function in guinea-pigs T.-Drinkovic, D.
 2006
 5 S1 p. S9-
1 p.
 artikel
20 307 Altered body composition in males homozygous for the Delta F508 mutation Morton, A.M.
 2006
 5 S1 p. S72-
1 p.
 artikel
21 75 Anaerobic survival of Pseudomonas aeruginosa requires the Usp-like stress protein PA3309 Schreiber, K.
 2006
 5 S1 p. S17-
1 p.
 artikel
22 15 Analysis of candidate genes as modifiers of Cystic Fibrosis Dorfman, R.
 2006
 5 S1 p. S4-
1 p.
 artikel
23 18 Analysis of the CLCA-gene cluster as a modulator of Cystic Fibrosis Kolbe, E.W.
 2006
 5 S1 p. S5-
1 p.
 artikel
24 398 An annual review tool: assessing nursing and psychological needs Yorston, B.
 2006
 5 S1 p. S88-
1 p.
 artikel
25 500 An audit of adherence to prescribed SeretideO by in-patients at an adult Cystic Fibrosis centre Redfern, J.
 2006
 5 S1 p. S110-
1 p.
 artikel
26 320 An audit of low profile gastrostomy devices — is rupture of the internal retention balloon more common in CF? Hambleton, J.
 2006
 5 S1 p. S75-
1 p.
 artikel
27 114 An audit of the clinical impact of oral azithromycin in children with chronic Pseudomonas airway infection Shenoy, A.
 2006
 5 S1 p. S25-
1 p.
 artikel
28 316 An audit of the food provision for inpatients with Cystic Fibrosis Roberts, J.
 2006
 5 S1 p. S74-
1 p.
 artikel
29 499 An audit to identify the outcomes of an antibiotic desensitisation programme Redfern, J.
 2006
 5 S1 p. S110-
1 p.
 artikel
30 317 Anemia in adult patients with cystic fibrosis (CF) Hansen, S.
 2006
 5 S1 p. S74-
1 p.
 artikel
31 77 An interaction between 14-3-3 and ExoS of P. aeruginosa is necessary for ExoS cytoxicity and enzymatic activity Yasmin, L.
 2006
 5 S1 p. S18-
1 p.
 artikel
32 502 An investigation into the prevalence of the use of complementary (CM) and over the counter (OTC) medicines (MEDS) by patients (pts) in an adult Cystic Fibrosis centre Redfern, J.
 2006
 5 S1 p. S111-
1 p.
 artikel
33 486 Announcement of diagnosis and quality approach in CF Guégantonl, L.
 2006
 5 S1 p. S107-
1 p.
 artikel
34 2 A novel homozygous CFTR mutation in a Chinese man with infertility Gjevre, J.
 2006
 5 S1 p. S1-
1 p.
 artikel
35 119 Antimicrobial susceptibilities of anaerobic bacteria isolated from the sputum of Cystic Fibrosis patients Field, T.R.
 2006
 5 S1 p. S27-
1 p.
 artikel
36 419 A patient-held diary in Cystic Fibrosis (CF) Chinuck, R.S.
 2006
 5 S1 p. S93-
1 p.
 artikel
37 76 A Pseudomonas aeruginosa strain isolated from Cystic Fibrosis lung with strong adherence to human tracheobronchial mucin Chang, T.
 2006
 5 S1 p. S17-
1 p.
 artikel
38 290 Aquagenic wrinkling of the palms in patients with Cystic Fibrosis: a pilot study Tolland, J.P.
 2006
 5 S1 p. S68-
1 p.
 artikel
39 311 A randomised controlled trial of a behavioural nutrition education programme “Eat Well with CF” for adults with CF Watson, H.
 2006
 5 S1 p. S73-
1 p.
 artikel
40 191 A retrospective study to assess the response to nebulised salbutamol during a period of stability in adult patients with Cystic Fibrosis Hughes, T.
 2006
 5 S1 p. S44-
1 p.
 artikel
41 435 A review of pulmozyme use in children on Teesside Lindsay, E.
 2006
 5 S1 p. S97-
1 p.
 artikel
42 150 Assessment of molecular methods for the rapid identification of Burkholderia cepacia complex (Bcc)-positive sputa Brown, A.R.
 2006
 5 S1 p. S34-
1 p.
 artikel
43 309 Assessment of nutritional status of Italian CF patients Coruzzo, A.
 2006
 5 S1 p. S72-
1 p.
 artikel
44 288 Assisted reproductive technique in men with Cystic Fibrosis Hubert, D.
 2006
 5 S1 p. S67-
1 p.
 artikel
45 141 A study of duration of airborne contamination by a new transmissible multiresistant Pseudomonas aeruginosa strain Meyer, P.
 2006
 5 S1 p. S32-
1 p.
 artikel
46 403 A survey of self medication in an adult Cystic Fibrosis centre Bowling, A.
 2006
 5 S1 p. S89-
1 p.
 artikel
47 354 Attitudes to exercise in adult CF patients Scott, E.
 2006
 5 S1 p. S78-
1 p.
 artikel
48 431 Audit of End-of-Life care in Cystic Fibrosis in Australia Finlayson, E.
 2006
 5 S1 p. S96-
1 p.
 artikel
49 275 Audit of screening and diagnosis of Cystic Fibrosis related diabetes King, E.C.
 2006
 5 S1 p. S64-
1 p.
 artikel
50 155 A UK national audit of MRSA prevalence and eradication strategies in Cystic Fibrosis Dewar, J.C.
 2006
 5 S1 p. S35-
1 p.
 artikel
51 Author index 2006
 5 S1 p. S115-5123
NaN p.
 artikel
52 372 A 5 year study of newly diagnosed CF patients in a screened population Murray, J.
 2006
 5 S1 p. S82-
1 p.
 artikel
53 115 Azithromycin affects the processing of tight junction proteins and ENaC in human airway epithelia in vitro Asgrimsson, V.
 2006
 5 S1 p. S26-
1 p.
 artikel
54 66 Bacterial diversity in the Cystic Fibrosis lung: geographical differences in community composition and distribution Stressmann, A.F.
 2006
 5 S1 p. S15-
1 p.
 artikel
55 27 Basal control of CFTR gene expression by bicarbonate-sensitive soluble adenylyl cyclase in Calu-3 cells Baudouin-Legros, M.
 2006
 5 S1 p. S6-
1 p.
 artikel
56 215 Baseline pulmonary function as a predictor of blood oxygenation while breathing a normobaric, hypoxic gas mixture in adults with Cystic Fibrosis de Keiser, A.
 2006
 5 S1 p. S50-
1 p.
 artikel
57 276 Bone age in English children with CF using the RUS (TW2) method Hattingh, L.
 2006
 5 S1 p. S64-
1 p.
 artikel
58 278 Bone mineral density (BMD) in Cystic Fibrosis patients (CFP) Cunha, C.A.P
 2006
 5 S1 p. S65-
1 p.
 artikel
59 277 Bone mineral density in patients with Cystic Fibrosis of Yaroslavl regional center Asherova, I.K.
 2006
 5 S1 p. S65-
1 p.
 artikel
60 162 BPI-ANCA predicts prognosis in CF Carlsson, M.
 2006
 5 S1 p. S37-
1 p.
 artikel
61 360 Brazilian Cystic Fibrosis physiotherapy protocol appliance results Santos, C.I.S.
 2006
 5 S1 p. S79-
1 p.
 artikel
62 440 “Breathe Easily”: An educational program to improve patients' adherence to daily inhalations Armoni, S.
 2006
 5 S1 p. S98-
1 p.
 artikel
63 442 Building a bridge between primary and secondary CF care Colpaert, K.
 2006
 5 S1 p. S99-
1 p.
 artikel
64 148 Burkholderia cepacia complex isolation and identification in a Turkish CF Unit Yurdaku, P.
 2006
 5 S1 p. S34-
1 p.
 artikel
65 32 Butyrate affects ENaC expression and sodium absorption in colonic epithelial cells Iordache, C.
 2006
 5 S1 p. S7-
1 p.
 artikel
66 229 CF-asthma and bronchiectasis-asthma: determination with AMP bronchoprovocation and sputum properties Aslan, A.T.
 2006
 5 S1 p. S54-
1 p.
 artikel
67 514 CF knowledge evaluation among medical students in Poland Krzyzanowski, M.
 2006
 5 S1 p. S114-
1 p.
 artikel
68 467 CF National registry in Slovakia Kayserova, H.
 2006
 5 S1 p. S102-
1 p.
 artikel
69 489 CF screened newborns with at least one R117H mutation: immunoreactive trypsinogen (IRT) and sweat test values, polyT and clinical symptoms Munck, A.
 2006
 5 S1 p. S107-
1 p.
 artikel
70 26 CFTR and MDR mRNA expression in patients with Cystic Fibrosis before and after 6 months of Azithromycin Oliynyk, I.
 2006
 5 S1 p. S6-
1 p.
 artikel
71 506 Change in cost of care, clinical condition and life expectancy of patients with Cystic Fibrosis in Moscow (Russia) over a ten year period Kashirskaya, N.
 2006
 5 S1 p. S112-
1 p.
 artikel
72 116 Characterisation of bacterial community composition in Cystic Fibrosis lung infection using biofilm models Spasenovski, T.
 2006
 5 S1 p. S26-
1 p.
 artikel
73 130 Characteristics of a new transmissible multiresistant Pseudomonas aeruginosa strain with a unique genotype Meyer, P.
 2006
 5 S1 p. S29-
1 p.
 artikel
74 122 Characterization of Pseudomonas aeruginosa populations in sputum from CF lungs using FISH, various staining methods and confocal microscopy Haagensen, J.A.J.
 2006
 5 S1 p. S27-
1 p.
 artikel
75 349 Chest physiotherapy in Cystic Fibrosis: short-term effects of Autogenic Drainage combined with wet inhalation of saline (saline-AD) versus Autogenic Drainage combined with Intrapulmonary Percussive Ventilation with saline (IPV-AD) Van Cauwelaert, K.
 2006
 5 S1 p. S77-
1 p.
 artikel
76 371 Chest strength and mobility training: a new approach to airways clearance Demryl, A.
 2006
 5 S1 p. S82-
1 p.
 artikel
77 361 Cleaning a Positive Expiratory Pressure (PEP) mask: an investigation of patient routines Vreys, M.
 2006
 5 S1 p. S80-
1 p.
 artikel
78 113 Clinical and immunodulatory effects of once weekly azithromycin treatment in Cystic Fibrosis patients chronically infected with Pseudomonas aeruginosa Steinkamp, G.
 2006
 5 S1 p. S25-
1 p.
 artikel
79 296 Clinical effect of zinc (Zn) supplements in cystic fibrosis (CF) patients Van Biervhet, S.
 2006
 5 S1 p. S69-
1 p.
 artikel
80 190 Clinical evolution of Cystic Fibrosis patients in diary treatment for four years with rhDNase Largo, I.
 2006
 5 S1 p. S44-
1 p.
 artikel
81 149 Clinical features of Pseudomonas aeruginosa (Pa) negative Cystic Fibrosis (CF) patients with the history of Pa infection Vavrova, V.
 2006
 5 S1 p. S34-
1 p.
 artikel
82 251 Clinical impact of symptomatic recurrent chronic pancreatitis in patients with cystic fibrosis (CF) Puleston, J.
 2006
 5 S1 p. S58-
1 p.
 artikel
83 185 Clinical pharmacology study of a new tobramycin solution for nebulisation Poli, G.
 2006
 5 S1 p. S43-
1 p.
 artikel
84 69 Clinical situations and mucoid transition of Pseudomonas aeruginosa in Cystic Fibrosis patients Martha, B.
 2006
 5 S1 p. S16-
1 p.
 artikel
85 200 Clinical usefulness of bronchoalveolar lavage (BAL) of patients with Cystic Fibrosis Dalberg, J.
 2006
 5 S1 p. S46-
1 p.
 artikel
86 262 Coinheritance of Gilbert syndrome associated UGT1A1 mutation increases the risk of gallstones in CF Barker, M.
 2006
 5 S1 p. S61-
1 p.
 artikel
87 508 Collective therapeutic education for Cystic Fibrosis children in Nantes (France) David, V.
 2006
 5 S1 p. S112-
1 p.
 artikel
88 160 Colonization of Cystic Fibrosis patients with Aspergillus fumigatus is a recurrent phenomenon de Valk, H.A.
 2006
 5 S1 p. S37-
1 p.
 artikel
89 188 Combining microbiological culture, PCR and serology increases Pseudomonas aeruginosa diagnosis in CF da Silva Filho, L.V.E.
 2006
 5 S1 p. S43-
1 p.
 artikel
90 346 Community physiotherapy for newly diagnosed infants with Cystic Fibrosis (newborn screening) McAleer, R.D.
 2006
 5 S1 p. S76-
1 p.
 artikel
91 357 Community physiotherapy: Meeting families' expectations Cole, P.
 2006
 5 S1 p. S79-
1 p.
 artikel
92 216 Compact and portable gas mixing measurements using a photoacoustic analyzer Horsley, A.R.
 2006
 5 S1 p. S50-
1 p.
 artikel
93 121 Comparative activity of linezolid, quinupristin/dalfopristin and vancomycin against biofilm produced by Cystic Fibrosis (CF) isolates of Staphylococcus aureus (SA) normal and small colony variant (SCV) phenotypes Morelli, P.
 2006
 5 S1 p. S27-
1 p.
 artikel
94 223 Comparing the clinical evolution of Cystic Fibrosis patients with meconium ileus and with nonmeconium ileus diagnosed under two months Pekcan, S.
 2006
 5 S1 p. S52-
1 p.
 artikel
95 126 Comparison of bacterial composition in spontaneous and successively induced sputum samples Rogers, G.
 2006
 5 S1 p. S28-
1 p.
 artikel
96 302 Comparison of nutritional status and lung function in children with Cystic Fibrosis and healthy controls Woestenenk, J.W.
 2006
 5 S1 p. S70-
1 p.
 artikel
97 182 Comparison of Pari LC-Star and -Plus nebulisers delivering 2.5 mg recombinant human deoxyribonuclease (rhDNase) Elkins, M.R.
 2006
 5 S1 p. S42-
1 p.
 artikel
98 479 Comparison of two sweat test methods in well infants at 5–6 weeks of age Jayaraj, R.
 2006
 5 S1 p. S105-
1 p.
 artikel
99 11 Complete molecular analysis of the CFTR gene in congenital absence of the vas deferens Grangeia, A.
 2006
 5 S1 p. S3-
1 p.
 artikel
100 265 Complications of diabetes in an adolescent Cystic Fibrosis population Chotirmall, S.H.
 2006
 5 S1 p. S62-
1 p.
 artikel
101 396 Consultation on transitional care needs of young people with cystic Fibrosis (CF) Claydon, A.
 2006
 5 S1 p. S87-
1 p.
 artikel
102 353 Contamination in positive expiratory pressure masks (PEP) Vreys, M.
 2006
 5 S1 p. S78-
1 p.
 artikel
103 261 Continous treatment with ursodeoxycholic acid (UDCA) for 15 years Espach, C.
 2006
 5 S1 p. S61-
1 p.
 artikel
104 301 Correlation of serum vitamin D with other measures of health in pancreatic sufficient adults with cystic fibrosis (CF) Clifton, I.J.
 2006
 5 S1 p. S70-
1 p.
 artikel
105 207 Correlation of six-minute walk distance with other clinical paramaters in adult Cystic Fibrosis patients Fila, L.
 2006
 5 S1 p. S48-
1 p.
 artikel
106 123 Cough swab versus cough plate in non-expectorating patients with Cystic Fibrosis Orska, T.
 2006
 5 S1 p. S28-
1 p.
 artikel
107 244 Creon® for children is preferred by parents of CF patients to Creon® 10000 MMS Munck, A.
 2006
 5 S1 p. S57-
1 p.
 artikel
108 281 Cross-sectional- and long-term-ultrasound bone density assessment in pediatric and adult patients with Cystic Fibrosis Mainz, J.
 2006
 5 S1 p. S66-
1 p.
 artikel
109 434 Cultural restraints and barriers to physical activity for male CF adults Greenop, D.
 2006
 5 S1 p. S97-
1 p.
 artikel
110 43 Culture of respiratory epithelial cells on copolymer-coated wires Servetnyk, Z.
 2006
 5 S1 p. S10-
1 p.
 artikel
111 28 Curcumin rescues deltaF508-CFTR via the keratin 18 network Lipecka, J.
 2006
 5 S1 p. S6-
1 p.
 artikel
112 234 Cystic Fibrosis and ciliary dyskinesia González, D.M.
 2006
 5 S1 p. S55-
1 p.
 artikel
113 441 Cystic fibrosis (CF) annual review documentation … from paper to the web King, F.
 2006
 5 S1 p. S99-
1 p.
 artikel
114 10 cystic fibrosis: genetic-clinical correlation González, C.
 2006
 5 S1 p. S3-
1 p.
 artikel
115 466 Cystic Fibrosis in Iceland 1955–2005; incidence, survival and CFT mutations in the Icelandic population Bergsteinsson, H.
 2006
 5 S1 p. S102-
1 p.
 artikel
116 269 Cystic Fibrosis related diabetes: the presence of microvascular diabetic complications Andersen, H.U.
 2006
 5 S1 p. S63-
1 p.
 artikel
117 202 Cystic Fibrosis sputum samples: too much, too soon? Waine, D.J.
 2006
 5 S1 p. S47-
1 p.
 artikel
118 413 Decision-making about pregnancy for women with CF Simcox, A.
 2006
 5 S1 p. S92-
1 p.
 artikel
119 270 Decline in lung function and BMI prior to the diagnosis of CFRD and the impact of gender Brown, J.
 2006
 5 S1 p. S63-
1 p.
 artikel
120 510 “Defeat Cystic Fibrosis” student project in Poland Krzyzanowskil, M.
 2006
 5 S1 p. S113-
1 p.
 artikel
121 152 Delineation of five new species within the Burkholderia cepacia complex Vanlaere, E.
 2006
 5 S1 p. S35-
1 p.
 artikel
122 177 Delivery of tobramycin via the I-nebTM adaptive aerosol delivery (AADO) system and the Pari LC Plus® nebulizer Hardaker, L.E.
 2006
 5 S1 p. S41-
1 p.
 artikel
123 47 Denufosol tetrasodium inhalation solution: results from two phase 2 trials in CF patients with mild to moderate lung disease Smiley, L.
 2006
 5 S1 p. S11-
1 p.
 artikel
124 377 Depression, quality of life, and physical activity in parents of children with Cystic Fibrosis Arikan, H.
 2006
 5 S1 p. S84-
1 p.
 artikel
125 73 Detection of antibodies to Pseudomonas aeruginosa in oral fluid from patients with Cystic Fibrosis Weisner, A.M.
 2006
 5 S1 p. S17-
1 p.
 artikel
126 485 Detection of CFTR mutations using a 4-MATTM microarray technology Van Loon, C.
 2006
 5 S1 p. S106-
1 p.
 artikel
127 211 Determinants of dyspnoea in Cystic Fibrosis: impact of inspiratory muscles endurance Leroy, S.
 2006
 5 S1 p. S49-
1 p.
 artikel
128 474 Determination of an immunoreactive trypsinogen (IRT) cut-off value for a neonatal CF screening program Montgomery, M.D.
 2006
 5 S1 p. S104-
1 p.
 artikel
129 422 Developing an educational package for CF children aged 6–12, in order to improve their compliance Vercaeren, G.
 2006
 5 S1 p. S94-
1 p.
 artikel
130 118 Development of tolerance to the antimicrobial peptide Colistin in Pseudomonas aeruginosa biofilms Pamp, S.I.
 2006
 5 S1 p. S26-
1 p.
 artikel
131 473 Diagnosing and managing of Cystic Fibrosis patients in Western Ukraine Makukh, H.
 2006
 5 S1 p. S103-
1 p.
 artikel
132 72 Diagnosis of Pseudomonas aeruginosa infection using microbial, molecular-biology and serology techniques Bartosova, J.
 2006
 5 S1 p. S16-
1 p.
 artikel
133 187 Diagnostic value of Pseudomonas aeruginosa antibodies in Cystic Fibrosis Ratjen, E.
 2006
 5 S1 p. S43-
1 p.
 artikel
134 257 Different evolution in CF patients with hepatobiliary disease and identical genotype Popa, I.M.
 2006
 5 S1 p. S60-
1 p.
 artikel
135 225 Difficult classification and management of pulmonary aspergillosis (PA) in Cystic Fibrosis De Schutter, I.
 2006
 5 S1 p. S53-
1 p.
 artikel
136 139 DNA-chip based high throughput analysis of the population structure of Pseudomonas aeruginosa Wiehlmann, L.
 2006
 5 S1 p. S31-
1 p.
 artikel
137 117 DNA release in Pseudomonas aeruginosa biofilms Yang, L.
 2006
 5 S1 p. S26-
1 p.
 artikel
138 420 Does an information leaflet prepare parents for a sweat test? Results of a questionnaire Jayaraj, R.
 2006
 5 S1 p. S93-
1 p.
 artikel
139 193 Does Chlamydophila pneumoniae play a role in Cystic Fibrosis? Schmidt, S.M.
 2006
 5 S1 p. S45-
1 p.
 artikel
140 170 Does defective apoptosis play a role in CF lung disease? Yalcin, E.
 2006
 5 S1 p. S39-
1 p.
 artikel
141 273 Does insulin treatment influence growth and lung function in children with abnormal oral glucose tolerance test (OGTT) but normal fasting glucose? Hardy, J.
 2006
 5 S1 p. S64-
1 p.
 artikel
142 175 Dosing tobramycin in the inhalation therapy of Cystic Fibrosis — a comparison of LC PLUS used in breath triggered mode and EFLOW RAPID Pechtold, O.
 2006
 5 S1 p. S40-
1 p.
 artikel
143 145 Do transmissible strains of Pseudomonas aeruginosa influence morbidity and mortality for patients with CF? Smith, C.M.
 2006
 5 S1 p. S33-
1 p.
 artikel
144 84 Dynamics of the Staphylococcus aureus nasal carriage and upper airway colonization/infection in young Cystic Fibrosis patients Ridder-Schaphorn, S.
 2006
 5 S1 p. S19-
1 p.
 artikel
145 227 Early detection of exacerbation of allergic bronchopulmonary aspergillosis in Cystic Fibrosis by lung function testing Schuler, D.
 2006
 5 S1 p. S53-
1 p.
 artikel
146 98 Early eradication therapy for Pseudomonas aeruginosa: impact of effective communication between the laboratory and clinical staff Denton, M.
 2006
 5 S1 p. S21-
1 p.
 artikel
147 99 Early eradication therapy for Pseudomonas aeruginosa: impact of prior clinical status and choice of antibiotic regimen on eradication rates Denton, M.
 2006
 5 S1 p. S22-
1 p.
 artikel
148 217 Early referral to a specialised centre is associated with a better respiratory outcome Lebecque, P.
 2006
 5 S1 p. S51-
1 p.
 artikel
149 97 Early treatment of first Pseudomonas aeruginosa isolation in Cystic Fibrosis patients Gartner, S.
 2006
 5 S1 p. S21-
1 p.
 artikel
150 96 Economic effects of “first growth” therapy for Pseudomonas aeruginosa in Cystic Fibrosis patients — 1995—2005 Davidson, A.G.F.
 2006
 5 S1 p. S21-
1 p.
 artikel
151 507 Economic impact of the Cystic Fibrosis management guideline implementation in one region of France Huot, L.
 2006
 5 S1 p. S112-
1 p.
 artikel
152 424 Education of parents with young Cystic Fibrosis children less than 5 years old Sermet-Gaudelus, I.
 2006
 5 S1 p. S94-
1 p.
 artikel
153 400 Effecting change with creative thinking: outpatient intravenous antibiotic utilisation Player, R.
 2006
 5 S1 p. S88-
1 p.
 artikel
154 226 Effect of broncho-pulmonary aspergillosis (ABPA) on progression of lung function in children with Cystic Fibrosis Kraemer, R.
 2006
 5 S1 p. S53-
1 p.
 artikel
155 289 Effect of choline and related supplements on methionine-homocysteine metabolism and glutathione status in children with Cystic Fibrosis Innis, S.M.
 2006
 5 S1 p. S68-
1 p.
 artikel
156 142 Effect of different environmental conditions on survival of Pseudomonas aeruginosa (PA) within artificially generated aerosols Clifton, I.J.
 2006
 5 S1 p. S32-
1 p.
 artikel
157 297 Effect of feeding DHA on the fatty acid composition of intestinal mucosa in adults with CF Clandinin, M.T.
 2006
 5 S1 p. S69-
1 p.
 artikel
158 144 Effect of nebuliser suspension solutions on survival of Pseudomonas aeruginosa (PA) within artificially generated aerosols Clifton, I.J.
 2006
 5 S1 p. S33-
1 p.
 artikel
159 101 Effect of TOBI® on the eradication of Pseudomonas colonisation Marchettii, E.
 2006
 5 S1 p. S22-
1 p.
 artikel
160 51 Effects of glargine insulin in patient with Cystic Fibrosis (CF) and impaired glucose tolerance (IGT) Ciampalini, P.
 2006
 5 S1 p. S12-
1 p.
 artikel
161 37 Effects of hyperosmotic stress on cultured airway epithelial cells Nilsson, H.
 2006
 5 S1 p. S9-
1 p.
 artikel
162 465 Effects of socioeconomic status, race and ethnicity on quality of life in a national database Quittnert, A.
 2006
 5 S1 p. S102-
1 p.
 artikel
163 176 Effects of tobramycin solution for inhalation in patients with Pseudomonas aeruginosa chronic colonization Sole, A.
 2006
 5 S1 p. S40-
1 p.
 artikel
164 374 Efficacy of physical exercise playing a video game for mucus clearance in patients with Cystic Fibrosis Aquino, A.
 2006
 5 S1 p. S83-
1 p.
 artikel
165 109 Efficacy of Temocillin in CF: a retrospective pilot study Kent, L.
 2006
 5 S1 p. S24-
1 p.
 artikel
166 243 Enhanced coefficient of fat absorption using a novel pancreatic enzyme preparation, ALTU-135, with concomitant use of a proton pump inhibitor Borowitz, D.
 2006
 5 S1 p. S56-
1 p.
 artikel
167 146 Epidemiology of Burkholderia species infection at a large adult Cystic Fibrosis centre Dodd, M.E.
 2006
 5 S1 p. S33-
1 p.
 artikel
168 159 Epidemiology of fungi in culture sputum from Cystic Fibrosis patients in Israel Shoseyov, D.
 2006
 5 S1 p. S36-
1 p.
 artikel
169 95 Eradication strategies for early Pseudomonas aeruginosa: a meta-analysis Wood, D.M.
 2006
 5 S1 p. S21-
1 p.
 artikel
170 189 Eradication therapy against early Pseudomonas aeruginosa infection in patients with Cystic Fibrosis Grzejdziak, A.D.
 2006
 5 S1 p. S44-
1 p.
 artikel
171 34 ERK1/2 activation and IL-8 secretion of Cystic Fibrosislung epithelial cells in response to oxidative stress Boncoeur, E.
 2006
 5 S1 p. S8-
1 p.
 artikel
172 348 Establishing paediatric patients on an Adaptive Aerosol Delivery (AAD) device McCormack, P.
 2006
 5 S1 p. S76-
1 p.
 artikel
173 European CF survey: a concerted action on the identity and frequency of CFTR gene mutations among Turkish and North-African CF patients in Europe Lakeman, P.
 2006
 5 S1 p. S1-
1 p.
 artikel
174 16 European CF twin and sibling study: CD14 as a genetic modulator of Pseudomonas aeruginosa infection in Cystic Fibrosispatients Kumar, V.
 2006
 5 S1 p. S4-
1 p.
 artikel
175 312 Evaluating the process of a behavioural nutrition education programme “Eat Well with CF” for adults with CF Watson, H.
 2006
 5 S1 p. S73-
1 p.
 artikel
176 395 Evaluation of a pilot Cystic Fibrosis “pre-graduation” clinic Gravelle, A.
 2006
 5 S1 p. S87-
1 p.
 artikel
177 240 Exocrine pancreatic function and resting energy expenditure in Cystic Fibrosis Moudiou, T.
 2006
 5 S1 p. S56-
1 p.
 artikel
178 241 Exocrine pancreatic function evaluation in patients with Cystic Fibrosis and pancreatic sufficiency: a correlation study Wilschanski, M.
 2006
 5 S1 p. S56-
1 p.
 artikel
179 83 Exopolysaccharide production in the Burkholderia cepacia in response to growth on onion agar Bartholdson, J.
 2006
 5 S1 p. S19-
1 p.
 artikel
180 55 Exploratory Phase II study of recombinant canine gastric lipase (r-GL, Merispase®) in association with pancreatic extracts (PE) for the treatment of steatorrhea in CF patients inadequately controlled with high doses of PE Hubert, D.
 2006
 5 S1 p. S13-
1 p.
 artikel
181 397 Exploring adolescents' adherence to CF treatment regimes Cowlard, J.
 2006
 5 S1 p. S88-
1 p.
 artikel
182 13 Extensive CFTR mutational analysis in patients with CBAVD Amato, A.
 2006
 5 S1 p. S4-
1 p.
 artikel
183 428 Extramural care of the specialist CF social worker Tijtgat, A.
 2006
 5 S1 p. S95-
1 p.
 artikel
184 304 Fasting ghrelin and leptin levels in Cystic Fibrosis adolescents: relationship with body composition Stylianoul, Ch.
 2006
 5 S1 p. S71-
1 p.
 artikel
185 437 Fathers' experiences of the emotional impact of managing the care of their children with cystic fibrosis (CF) Hayes, C.C.
 2006
 5 S1 p. S98-
1 p.
 artikel
186 198 18FDG-PET/CT contribution to the assessment of lesion severity in Cystic Fibrosis (CF) Klein, M.
 2006
 5 S1 p. S46-
1 p.
 artikel
187 79 Fighting Pseudomonas aeruginosa by exploiting its communication — quorum sensing Bjarnsholt, T.
 2006
 5 S1 p. S18-
1 p.
 artikel
188 252 First capsule endoscopy studies in Cystic Fibrosis: description of CF enteropathy Wilschanski, M.
 2006
 5 S1 p. S59-
1 p.
 artikel
189 491 Flexible bronchoscopy and oesophageal pH monitoring in children newly diagnosed with Cystic Fibrosis Hilliard, T.
 2006
 5 S1 p. S108-
1 p.
 artikel
190 Foreword 2006
 5 S1 p. v-
1 p.
 artikel
191 282 Frequency and risk factors of osteopenia/osteoporosis in children with Cystic Fibrosis Kapustina, T.
 2006
 5 S1 p. S66-
1 p.
 artikel
192 376 Functional health status in Cystic Fibrosis Saveci, S.
 2006
 5 S1 p. S83-
1 p.
 artikel
193 29 Functional interaction between CFTR and the renal sodium-phosphate cotransporter (NPT IIa) Bakouh, N.
 2006
 5 S1 p. S7-
1 p.
 artikel
194 460 Gender differences in the Scandinavian CF population Olesen, H.V
 2006
 5 S1 p. S101-
1 p.
 artikel
195 138 Genomic islands from Pseudomonas aeruginosa CF-isolates spread the barriers of bacterial species Klockgether, J.
 2006
 5 S1 p. S31-
1 p.
 artikel
196 9 Genotype-phenotype characteristics in Cystic Fibrosis — study on 20 children with Cystic Fibrosisin Romania Mosescu, S.
 2006
 5 S1 p. S3-
1 p.
 artikel
197 8 Genotype/phenotype correlation in Cystic Fibrosisassociated hepatobiliary disease – is it real? Popa, I.M.
 2006
 5 S1 p. S2-
1 p.
 artikel
198 306 Growth parameters in Scandinavian CF patients Hjelte, L.
 2006
 5 S1 p. S71-
1 p.
 artikel
199 394 Harmonization of transition to the adult CF centre in Paris area Duguépéroux, I.
 2006
 5 S1 p. S87-
1 p.
 artikel
200 432 Healthy family members' attitude for improving QoL of the affected person — something more about the “survival guilt” Petrova, G.
 2006
 5 S1 p. S96-
1 p.
 artikel
201 258 Hepatobiliary disease in Cystic Fibrosis patients Popa, I.M.
 2006
 5 S1 p. S60-
1 p.
 artikel
202 426 Home intravenous (iv) antibiotic (ab) treatment: education to achieve complete patient autonomy Delvaux, I.
 2006
 5 S1 p. S95-
1 p.
 artikel
203 429 How are we doing? — The results of a patient satisfaction questionnaire Morton, A.M.
 2006
 5 S1 p. S96-
1 p.
 artikel
204 443 How easy is it to track the CF patients' lung transplant journey through their health records? McMullan, C.
 2006
 5 S1 p. S99-
1 p.
 artikel
205 103 How long can aminoglycosides be deferred using β-lactam alone for Pseudomonas aeruginosa (PA) in children with CF? Newberry, E.
 2006
 5 S1 p. S23-
1 p.
 artikel
206 476 How stable is immunoreactive trypsinogen (IRT) on newborn screening cards? Larsen, C.L.
 2006
 5 S1 p. S104-
1 p.
 artikel
207 41 Human adult airway epithelial basal cells are stem/progenitor cells of airway surface epithelium Hajj, R.
 2006
 5 S1 p. S10-
1 p.
 artikel
208 318 Hypovitaminosis A in a child with Cystic Fibrosis Lowdon, J.
 2006
 5 S1 p. S74-
1 p.
 artikel
209 151 Identification of Burkholderia cepacia complex using MALDI-TOF mass spectrometry Vanlaere, E.
 2006
 5 S1 p. S34-
1 p.
 artikel
210 7 Identification of DNA variants in non-coding regions of the CFTR gene Markiewicz, D.
 2006
 5 S1 p. S2-
1 p.
 artikel
211 147 Identification of genomovar status, virulence genes and genotyping of Burkholderia cepacia complex strains isolated from Brazilian CF patients Martins, K.M.
 2006
 5 S1 p. S33-
1 p.
 artikel
212 373 Immediate effect of expiratory flow increase technique (EFIT) on spirometric parameters of Cystic Fibrosis (CF) patients Santos, C.I.S.
 2006
 5 S1 p. S83-
1 p.
 artikel
213 249 Immuno-Reactive Trypsinogen (IRT) reflects pancreatic status in CF and non-CF adults Middleton, P.G.
 2006
 5 S1 p. S58-
1 p.
 artikel
214 314 Implementing standards of care. How are we doing? How can we improve? Morton, A.M.
 2006
 5 S1 p. S73-
1 p.
 artikel
215 463 Improved survival in Cystic Fibrosis associated with the specialized center care Fustik, S.
 2006
 5 S1 p. S101-
1 p.
 artikel
216 501 Inappropriate routine prescribing in CF clinics Kanagarathnam, M.
 2006
 5 S1 p. S110-
1 p.
 artikel
217 472 Incidence of Cystic Fibrosis in high-risk Egyptian children and CFTR mutation analysis Naguib, M.L.
 2006
 5 S1 p. S103-
1 p.
 artikel
218 471 Increased age at diagnosis justifies CF neonatal screening Zemková, D.
 2006
 5 S1 p. S103-
1 p.
 artikel
219 197 Increased nitrite in exhaled breath condensate (EBC) in patients with CF: a product of pharyngo-oral bacterial activity Johannesson, M.
 2006
 5 S1 p. S46-
1 p.
 artikel
220 415 Increased segregation in an adult Cystic Fibrosis centre: the impact on patients' feelings and behavior Milnes, J.
 2006
 5 S1 p. S92-
1 p.
 artikel
221 82 Increasing levels of precipitating antibodies to Achromobacter xylosoxidans and Burkholderia multivorans reflect more aggressive pulmonary disease in chronically infected Cystic Fibrosis patients Bugge, B.
 2006
 5 S1 p. S19-
1 p.
 artikel
222 19 Influence of tumor necrosis factor gene polymorphisms on lung disease progression in children with Cystic Fibrosis Brouard, J.
 2006
 5 S1 p. S5-
1 p.
 artikel
223 509 Information and communication system for CF care: gathering actions and assistance Rault, G.
 2006
 5 S1 p. S112-
1 p.
 artikel
224 445 Inhalation therapy compliance in teen patients with Cystic Fibrosis González Peralta, N.
 2006
 5 S1 p. S100-
1 p.
 artikel
225 46 Inhaled dry powder mannitol (Bronchitol) improves FEV1 in Cystic Fibrosis Charlton, B.
 2006
 5 S1 p. S11-
1 p.
 artikel
226 368 Inhaling hypertonic saline — a useful method to obtain sputum in children and adults with CF Wenngren, E.
 2006
 5 S1 p. S81-
1 p.
 artikel
227 405 Insertion of peripheral long lines — empowering nursing staff Miller, H.
 2006
 5 S1 p. S90-
1 p.
 artikel
228 295 Intake of fat-soluble vitamins from supplements in adult patients with Cystic Fibrosis Hollander, E.
 2006
 5 S1 p. S69-
1 p.
 artikel
229 411 Interest of home visits in Cystic Fibrosis Clairicia, M.
 2006
 5 S1 p. S91-
1 p.
 artikel
230 90 Interest of measuring body composition to determine antibiotic dosing in Cystic Fibrosis Montcho, Y.
 2006
 5 S1 p. S19-
1 p.
 artikel
231 92 Intrapulmonary concentrations of tobramycin and ceftazidime achieved after intravenous administration for the treatment of Cystic Fibrosis lung infections Moriarty, T.E.
 2006
 5 S1 p. S20-
1 p.
 artikel
232 195 Intravenous antibiotics effects on spirometrics parameters of Cystic Fibrosis (CF) patients with acute pulmonary exacerbation infected with Pseudomonas aeruginosa Santos, C.I.S.
 2006
 5 S1 p. S45-
1 p.
 artikel
233 444 Intravenous therapy: a cost saving initiative Clough, D.
 2006
 5 S1 p. S99-
1 p.
 artikel
234 111 Introduction of chronic macrolide antibiotic therapy to a cystic fibrosis population Branagan, P.
 2006
 5 S1 p. S25-
1 p.
 artikel
235 120 Investigating the antibiotic susceptibilities of the Burkholderia cepacia complex (Bcc) Caraher, E.
 2006
 5 S1 p. S27-
1 p.
 artikel
236 171 Investigation of neutrophil apoptosis in Cystic Fibrosis children using a proteomic approach Moriceau, S.
 2006
 5 S1 p. S39-
1 p.
 artikel
237 54 In-vitro deposition study of a levofloxacin (LEV) solution into a novel human nasal cast model by the PARI SINUS™ Schuschnig, U.
 2006
 5 S1 p. S13-
1 p.
 artikel
238 74 Is BPI-ANCA in Pseudomonas aeruginosa colonized CF patients strain dependent? Carlsson, M.
 2006
 5 S1 p. S17-
1 p.
 artikel
239 461 Is CF more severe in females (F) than in males (M)? — Survival analysis from the Italian Cystic Fibrosis Registry (ICFR) Viviani, L.
 2006
 5 S1 p. S101-
1 p.
 artikel
240 271 Is earlier development of CFRD one possible reason for worse clinical findings in women with CFRD? Kämpfert, C.
 2006
 5 S1 p. S63-
1 p.
 artikel
241 512 Is living with CF a painful experience? Stock, D.A.
 2006
 5 S1 p. S113-
1 p.
 artikel
242 128 Isolation and identification of “difficult” pathogens from CF airways: molecular analysis results Cocchi, P.
 2006
 5 S1 p. S29-
1 p.
 artikel
243 232 Is there a correlation between pseudo-Bartter syndrome and pulmonary involvement in Cystic Fibrosis? Cobanoglu, N.
 2006
 5 S1 p. S54-
1 p.
 artikel
244 178 Itraconazole monotherapy for allergic bronchopulmonary aspergillosis in Cystic Fibrosis (CF) T-Drinkovic, D.
 2006
 5 S1 p. S41-
1 p.
 artikel
245 495 Kidney pathology in children with Cystic Fibrosis Tolstova, V.
 2006
 5 S1 p. S109-
1 p.
 artikel
246 253 Laparascopic fundoplication is an effective and safe treatment for gastro-oesophageal reflux disease (GORD) in adult Cystic Fibrosis Button, B.
 2006
 5 S1 p. S59-
1 p.
 artikel
247 6 Large deletions of the CFTR gene: new detection methods and indications for screening Schneider, M.
 2006
 5 S1 p. S2-
1 p.
 artikel
248 204 Leptin levels in adult CF patients Schahin, S. Pour
 2006
 5 S1 p. S47-
1 p.
 artikel
249 3 L138ins mutation of CFTR gene in CF patients from Russia Radionovitch, A.
 2006
 5 S1 p. S1-
1 p.
 artikel
250 305 “Little scissors in my tummy!” A booklet about pancreatic enzymes for children with CF De Rijcke, K.
 2006
 5 S1 p. S71-
1 p.
 artikel
251 259 Liver disease in Cystic Fibrosis — prevalence and predisposing factors Schibli, S.
 2006
 5 S1 p. S60-
1 p.
 artikel
252 391 Living and working with CF Hauermans, T.
 2006
 5 S1 p. S86-
1 p.
 artikel
253 196 Longitudinal monitoring of infective exacerbations in cystic fibrosis by sputum calprotectin: from biomarker discovery to clinical application Gray, R.D.
 2006
 5 S1 p. S45-
1 p.
 artikel
254 201 Longitudinal monitoring of paediatric Cystic Fibrosis lung disease using nitrite in exhaled breath condensate Moeller, A.
 2006
 5 S1 p. S47-
1 p.
 artikel
255 183 Long-term administration of nebulised tobramycin in patients with Cystic Fibrosis Chuchalin, A.
 2006
 5 S1 p. S42-
1 p.
 artikel
256 274 Long term complication screening in Cystic Fibrosis related diabetes Miller, H.
 2006
 5 S1 p. S64-
1 p.
 artikel
257 218 Long term non-invasive positive pressure ventilation is associated with a stabilisation in the decline of lung function Fauroux, B.
 2006
 5 S1 p. S51-
1 p.
 artikel
258 186 Long-term outcome of different strategies following the first isolation of Pseudomonas aeruginosa Kirchner, E.
 2006
 5 S1 p. S43-
1 p.
 artikel
259 505 Lung HRCT and MRI findings in pediatric patients with Cystic Fibrosis Daltro, P.A.
 2006
 5 S1 p. S111-
1 p.
 artikel
260 222 Lung transplantation in CF patients on mechanical ventilation and ECMO Mared, L.
 2006
 5 S1 p. S52-
1 p.
 artikel
261 345 Managing community exercise referrals: does cross infection occur? Riley, D.
 2006
 5 S1 p. S76-
1 p.
 artikel
262 386 Managing ‘normality’ and CF during adolescence: a qualitative study Demetriades, L.
 2006
 5 S1 p. S85-
1 p.
 artikel
263 165 Mannan-binding-lectin-associated serine protease 2 (MASP-2)—a major modifier of CF lung disease? Olesen, H.V.
 2006
 5 S1 p. S38-
1 p.
 artikel
264 166 Mast cell activation and oxidative stress may be key factors in pulmonary destruction in Cystic Fibrosis Schiøtz, P.O.
 2006
 5 S1 p. S38-
1 p.
 artikel
265 255 Meconium ileus: an Irish experience Lucey, J.
 2006
 5 S1 p. S59-
1 p.
 artikel
266 392 Mental health and sense of coherence in Swedish Cystic Fibrosis adults. A pilot study Bergsten Brucefors, A.
 2006
 5 S1 p. S86-
1 p.
 artikel
267 108 Metallo R-lactamase-producing Pseudomonas aeruginosa in a Cystic Fibrosis patient: persistence over a 6-year period Campana, S.
 2006
 5 S1 p. S24-
1 p.
 artikel
268 125 Microbiology of the pulmonary secretions in Cystic Fibrosis (CF) in a pediatric center: 18 years experience Galantik, L.
 2006
 5 S1 p. S28-
1 p.
 artikel
269 132 Molecular epidemiology and dynamics of chronic Pseudomonas aeruginosa populations in Cystic Fibrosis lungs Jelsbak, L.
 2006
 5 S1 p. S30-
1 p.
 artikel
270 156 Molecular epidemiology of Mycobacterium abscessus colonizing Cystic Fibrosis (CF) patients in Western Sweden Jönsson, B.
 2006
 5 S1 p. S36-
1 p.
 artikel
271 129 Molecular epidemiology of the longitudinal course of the Pseudomonas aeruginosa infection in Cystic Fibrosis Cramer, N.
 2006
 5 S1 p. S29-
1 p.
 artikel
272 4 Molecular identification of complex alleles in the CFTR gene Porcaro, L.
 2006
 5 S1 p. S1-
1 p.
 artikel
273 133 Molecular techniques should replace conventional biochemical methods for identification of nonfermentative Gram-negative rods including atypical Pseudomonas aeruginosa Petersson, A.-C.
 2006
 5 S1 p. S30-
1 p.
 artikel
274 140 Molecular typing of Pseudomonas aeruginosa strains isolated from sibling CF patients Ozcakir, O.
 2006
 5 S1 p. S32-
1 p.
 artikel
275 110 Monitoring of aminoglycoside serum levels in Cystic Fibrosis patients Lori, I.
 2006
 5 S1 p. S24-
1 p.
 artikel
276 390 Motivational interviewing as a bridge to shared decision making: Further results from a team-centred programme Ullrich, G.
 2006
 5 S1 p. S86-
1 p.
 artikel
277 106 Mucoid phenotype of Pseudomonas aeruginosa isolates is associated with decreased antimicrobial resistance Waine, D.J.
 2006
 5 S1 p. S23-
1 p.
 artikel
278 439 Multi-centre questionnaire survey of the incidence, prevalence and severity of urinary stress incontinence in women with CF in Scotland McIntosh, L.
 2006
 5 S1 p. S98-
1 p.
 artikel
279 127 Multilocus sequence typing databases for CF pathogens: identification of global epidemic clones, novel species, natural reservoirs, and relationships between environmental and clinical isolates Dowson, C.G.
 2006
 5 S1 p. S28-
1 p.
 artikel
280 494 Multiple brain abscesses in Cystic Fibrosis Gjevre, J.
 2006
 5 S1 p. S109-
1 p.
 artikel
281 158 Mycobacterium chelonae infection in a CF patient Travan, L.
 2006
 5 S1 p. S36-
1 p.
 artikel
282 480 NanoductO sweat conductivity measurements in 1000 subjects Desax, M.-C.
 2006
 5 S1 p. S105-
1 p.
 artikel
283 42 Nasal epithelial brushing: a valuable method to study airway epithelial cells in CF and non-CF infants Mosler, K.
 2006
 5 S1 p. S10-
1 p.
 artikel
284 483 Nasal potential difference measurements in Turkish CF patients Cinell, G.
 2006
 5 S1 p. S106-
1 p.
 artikel
285 52 Nebulisation of a novel Pseudomonas aeruginosa biofilm formation inhibiting sensing blocker by the eFlow® electronic nebuliser Tservistas, M.
 2006
 5 S1 p. S12-
1 p.
 artikel
286 478 Neonatal screening program for cystic fibrosis (CF) in Minas Gerais, Brazil Reis, E.J.C.
 2006
 5 S1 p. S105-
1 p.
 artikel
287 477 Newborn cystic fibrosis (CF) screening in Canada: considerations regarding the selection of a molecular genetic assay Bridgel, P.J.
 2006
 5 S1 p. S104-
1 p.
 artikel
288 475 Newborn cystic fibrosis (CF) screening in Canada: Our first experience Montgomery, M.D.
 2006
 5 S1 p. S104-
1 p.
 artikel
289 490 Newborn screening and atypical CF forms Padoan, R.
 2006
 5 S1 p. S108-
1 p.
 artikel
290 470 Newborn screening for CF in the Czech Republic: results from a pilot study Holubova, A.
 2006
 5 S1 p. S103-
1 p.
 artikel
291 134 Newly acquired Pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients' P. aeruginosa genotype correlate with environmental genotypes? Schelstraete, P.
 2006
 5 S1 p. S30-
1 p.
 artikel
292 220 Non-invasive ventilation (NIV): experience of Cystic Fibrosis Center of Genova Casciaro, R.
 2006
 5 S1 p. S51-
1 p.
 artikel
293 20 No point mutation in Keratin 8 and Keratin 18 genes, in Cystic Fibrosis patients with severe liver disorders Masson, F.
 2006
 5 S1 p. S5-
1 p.
 artikel
294 50 Novel in vivo anti-inflammatory action of azithromycin in CF subjects McKeon, D.J.
 2006
 5 S1 p. S12-
1 p.
 artikel
295 173 Novel steroids with anti-inflammatory activity that stimulate immunity: implications for treatment of Cystic Fibrosis Auci, D.L.
 2006
 5 S1 p. S40-
1 p.
 artikel
296 418 Nursing aspects of segregation policy van Hattem, M.
 2006
 5 S1 p. S93-
1 p.
 artikel
297 299 Nutritional intake in CF patients in Norway and Sweden Moen, I.E.
 2006
 5 S1 p. S70-
1 p.
 artikel
298 203 Nutritional status and lung function and sputum II-8/IL-10 levels in CF patients Korzeniewska, A.
 2006
 5 S1 p. S47-
1 p.
 artikel
299 303 Nutritional status of adult population in Cork University Hospital Howlett, C.
 2006
 5 S1 p. S71-
1 p.
 artikel
300 308 Nutritional therapy for catch-up growth in malnourished infants with Cystic Fibrosis — the role of semi-elemental formula with medium chain triglycerides Mosescu, S.
 2006
 5 S1 p. S72-
1 p.
 artikel
301 254 Omeprazole treatment of gastro-esophageal reflux in Cystic Fibrosis. How much is enough? Shoseyov, D.
 2006
 5 S1 p. S59-
1 p.
 artikel
302 268 Once daily long acting insulin achieves good glycaemic control in Cystic Fibrosis related diabetes (CFRD) McGinnity, T.
 2006
 5 S1 p. S62-
1 p.
 artikel
303 266 Oral glucose tolerance testing in CF adults — cross-sectional and longitudinal comparisons Middleton, P.G.
 2006
 5 S1 p. S62-
1 p.
 artikel
304 464 Paediatric Cystic Fibrosis care — at a District General Hospital Nagvekar, S.
 2006
 5 S1 p. S102-
1 p.
 artikel
305 245 Pancreatic enzymes consumption by CF patients in France Dyard, F.
 2006
 5 S1 p. S57-
1 p.
 artikel
306 250 Pancreatic enzyme use in adult patients with Cystic Fibrosis Pearson, C.E.
 2006
 5 S1 p. S58-
1 p.
 artikel
307 402 Parental involvement, does this continue in adulthood? Beckett, K.
 2006
 5 S1 p. S89-
1 p.
 artikel
308 365 Patient satisfaction with physiotherapy techniques for airway clearance in Cystic Fibrosis Dentiice, R.
 2006
 5 S1 p. S81-
1 p.
 artikel
309 410 Perception of pain and fear related to invasive procedures in children with Cystic Fibrosis: a study using CF adults recalls Neri, S.
 2006
 5 S1 p. S91-
1 p.
 artikel
310 209 Perception of shortness of breath and disability living allowance in adult Cystic Fibrosis Bari, S.
 2006
 5 S1 p. S49-
1 p.
 artikel
311 71 Phenotypic and genotypic characteristics of a Cystic Fibrosis epidemic strain of Pseudomonas aeruginosa Winstanley, C.
 2006
 5 S1 p. S16-
1 p.
 artikel
312 135 Phenotypic assessment of mucoid and nonmucoid Pseudomonas aeruginosa isolates from patients with Cystic Fibrosis Lee, B.
 2006
 5 S1 p. S30-
1 p.
 artikel
313 362 Physical activity and fitness in children with Cystic Fibrosis Adams, A.
 2006
 5 S1 p. S80-
1 p.
 artikel
314 355 Playing the board game “Airway” with children increases knowledge about CF lung disease van der Giessen, L.
 2006
 5 S1 p. S78-
1 p.
 artikel
315 57 Point assays for Cystic Fibrosis gene therapy (CFGT) Ogilvie, V.C.
 2006
 5 S1 p. S14-
1 p.
 artikel
316 363 Positive Expiratory Pressure therapy: to adhere or not to adhere? Vreys, M.
 2006
 5 S1 p. S80-
1 p.
 artikel
317 364 Postural changes in children and adolescents with Cystic Fibrosis Comi, P.B.M.
 2006
 5 S1 p. S80-
1 p.
 artikel
318 30 PPARγ agonists affect expression and trafficking of ΔF508 CFTR in epithelial cells Duszyk, M.
 2006
 5 S1 p. S7-
1 p.
 artikel
319 414 Pregnancy in Cystic Fibrosis — a multidisciplinary approach Lyons, A.M.
 2006
 5 S1 p. S92-
1 p.
 artikel
320 412 Pregnancy: The experience of an adult Cystic Fibrosis centre 1982–2005 Gumery, L.
 2006
 5 S1 p. S91-
1 p.
 artikel
321 285 Preliminary report of longitudinal changes in bone mineral density (BMD) in children and adolescents with CF Wolfe, S.
 2006
 5 S1 p. S67-
1 p.
 artikel
322 35 Presence of β3-adrenoceptor in human lung: overexpression in Cystic Fibrosis Bossard, E.
 2006
 5 S1 p. S8-
1 p.
 artikel
323 359 Prevalence and importance of muscle weakness in adults with CF Vrijsen, B.
 2006
 5 S1 p. S79-
1 p.
 artikel
324 228 Prevalence of aspergillus/allergic bronchopulmonary aspergillosis in a CF population Chotirmall, S.H.
 2006
 5 S1 p. S53-
1 p.
 artikel
325 157 Prevalence of nontuberculous mycobacteria infection in Cystic Fibrosis (CF) pediatric patients in Piedmont region of Italy Veljkovic, A.
 2006
 5 S1 p. S36-
1 p.
 artikel
326 283 Prevalence of osteopenia/osteoporosis in an adult CF centre Robertson, J.
 2006
 5 S1 p. S66-
1 p.
 artikel
327 231 Prevalence of sensitization to moulds in children with CF McKay, K.
 2006
 5 S1 p. S54-
1 p.
 artikel
328 192 Prevention of respiratory syncytial virus (RSV) infection in CF infants Miano, A.
 2006
 5 S1 p. S44-
1 p.
 artikel
329 409 Procedural pain in children with Cystic Fibrosis: an international survey on the methods used by CF centres to prevent and reduce it Festini, E.
 2006
 5 S1 p. S91-
1 p.
 artikel
330 487 Procedure for diagnostic announcement of Cystic Fibrosis by a multidisciplinary team Kerbrat, M.
 2006
 5 S1 p. S107-
1 p.
 artikel
331 246 Prognostic value of fecal elastase in children with Cystic Fibrosis Anne, C.
 2006
 5 S1 p. S57-
1 p.
 artikel
332 206 Progression of lung disease on pulmonary function tests (PFT) and high-resolution computed tomography (HRCT) in children and adolescents with Cystic Fibrosis Hatziagorou, E.
 2006
 5 S1 p. S48-
1 p.
 artikel
333 213 Progression of pulmonary hyperinflation and trapped gas associated with genetic factors in children with cystic fibrosis (CF) Kraemer, R.
 2006
 5 S1 p. S50-
1 p.
 artikel
334 78 Pseudomonas aeruginosa cupA encoded fimbria expression is regulated by a GGDEF and EAL domain dependent modulation of the intracellular level of cyclic diguanylate Meissner, A.
 2006
 5 S1 p. S18-
1 p.
 artikel
335 168 Pseudomonas aeruginosa flagellin is the major antigen for anti-pseudomonas IgY Nilsson, E.
 2006
 5 S1 p. S38-
1 p.
 artikel
336 136 Pseudomonas aeruginosa genotyping to control the efficacy of hygienic measures to segregate CF patients by P. aeruginosa status Wiehlmann, L.
 2006
 5 S1 p. S31-
1 p.
 artikel
337 70 Pseudomonas aeruginosa in the oral cavity: implications for lung infection in patients with Cystic Fibrosis Worlitzsch, D.
 2006
 5 S1 p. S16-
1 p.
 artikel
338 433 Psychosocial aspects of Turkish CF patients Cinel, G.
 2006
 5 S1 p. S97-
1 p.
 artikel
339 38 PUFA-mediated CI− transport regulation in model airway cells Krjukova, E.
 2006
 5 S1 p. S9-
1 p.
 artikel
340 181 Pulmonary deposition of inhaled tobramycin (TOBI), before and after physiotherapy and inhaled salbutamol and correlation with CF genotype Grotta, M.B.
 2006
 5 S1 p. S42-
1 p.
 artikel
341 180 Pulmonary deposition of inhaled tobramycin (TOBI), before and after physiotherapy and inhaled salbutamol and correlation with Shwachman Score (SS) in Cystic Fibrosis (CF) patients Grotta, M.B.
 2006
 5 S1 p. S41-
1 p.
 artikel
342 179 Pulmonary deposition of inhaled tobramycin (TOBI), before and after physiotherapy and inhaled salbutamol in Cystic Fibrosis (CF) patients Grotta, M.B.
 2006
 5 S1 p. S41-
1 p.
 artikel
343 219 Pulmonary function and growth in children with CF in relation to Pseudomonas aeruoginosa (PA) status and treatment regimen: an observational study Sanka, S.
 2006
 5 S1 p. S51-
1 p.
 artikel
344 199 Radiation dose estimation from thoracic CT scans in a CF population Chironon, R.
 2006
 5 S1 p. S46-
1 p.
 artikel
345 12 Rapid and reliable analysis of the CFTR locus in CBAVD patients des Georges, M.
 2006
 5 S1 p. S3-
1 p.
 artikel
346 484 Rapid and reliable genotyping of polymorphic loci influencing correct splicing of CFTR pre-mRNA using mass spectrometry Schaller, A.
 2006
 5 S1 p. S106-
1 p.
 artikel
347 5 Rapid screening for large rearrangement by a 2 PCR-multiplex strategy Audrezet, M.P.
 2006
 5 S1 p. S2-
1 p.
 artikel
348 94 Recording of antibiotic allergies and intolerances for patients with Cystic Fibrosis Temple, I.
 2006
 5 S1 p. S20-
1 p.
 artikel
349 284 Reduced bone density in patients with Cystic Fibrosis in the Republic of Macedonia Jakovska-Maretti, T.
 2006
 5 S1 p. S66-
1 p.
 artikel
350 53 Reduced treatment time for colistimethate sodium solution (Colistin CF) aerosolized by eFlow® rapid, a novel electronic nebuliser Keller, M.
 2006
 5 S1 p. S13-
1 p.
 artikel
351 174 Reduction of drug-dose and therapy-costs in the inhalation therapy with high dose tobramycin Brand, P.
 2006
 5 S1 p. S40-
1 p.
 artikel
352 49 Reduction of tumor necrosis factor alpha (TNFα) expression by azithromycin (AZM) in CF airway epithelial cells Cigana, C.
 2006
 5 S1 p. S12-
1 p.
 artikel
353 210 Relationship between breathlessness and exercise in adult CF patients Bari, S.
 2006
 5 S1 p. S49-
1 p.
 artikel
354 221 Relationship between growth, nutritional status and pulmonary function in children and adolescents with Cystic Fibrosis Hatziagorou, E.
 2006
 5 S1 p. S52-
1 p.
 artikel
355 194 Remote monitoring in the early detection of pulmonary exacerbation in Cystic Fibrosis Sarfaraz, S.
 2006
 5 S1 p. S45-
1 p.
 artikel
356 286 Renal disease in cystic fibrosis (CF) patients: a prospective multicenter observational cohort study Guillot, M.
 2006
 5 S1 p. S67-
1 p.
 artikel
357 287 Renal function and urolithiasis in Cystic Fibrosis Tramma, D.
 2006
 5 S1 p. S67-
1 p.
 artikel
358 208 Repeatability of cardiorespiratory measurements recorded by the LifeShirt Bradley, J.M.
 2006
 5 S1 p. S48-
1 p.
 artikel
359 310 Respiratory muscle strength and nutritional status in Cystic Fibrosis patients Moudiou, T.
 2006
 5 S1 p. S72-
1 p.
 artikel
360 58 Respiratory syncytial virus prophylaxis in Cystic Fibrosis: pilot study Prendiville, T.W.
 2006
 5 S1 p. S14-
1 p.
 artikel
361 404 Review of a bereavement service for families of adult CF people Govin, B.
 2006
 5 S1 p. S89-
1 p.
 artikel
362 93 Routine 3 monthly IV therapy in CF — is it worth it? Bari, S.
 2006
 5 S1 p. S20-
1 p.
 artikel
363 100 Safety of inhaled tobramycin nebuliser solution for treatment of early Pseudomonas aeruginosa infection: First results from the ELITE study Ratjen, E.
 2006
 5 S1 p. S22-
1 p.
 artikel
364 45 Safety, tolerability and efficacy of multiple, rising doses of aerosolized Moli1901 in CF patients Ratjen, F.
 2006
 5 S1 p. S11-
1 p.
 artikel
365 401 Scandinavian Nurse Specialist Group/Cystic Fibrosis (SNSG/CF) Bregnballe, V.
 2006
 5 S1 p. S89-
1 p.
 artikel
366 427 School and CF in France: a cohort study between 1999 and 2003 Popal, R.
 2006
 5 S1 p. S95-
1 p.
 artikel
367 423 “School starts: let's go on” — Preliminary results of a study on the need of follow-up neonatal screening psychological support program Catastini, P.
 2006
 5 S1 p. S94-
1 p.
 artikel
368 14 Screening for CFTR gene mutations and analysis of the TG12-T5 haplotype in infertile patients Tamburino, L.
 2006
 5 S1 p. S4-
1 p.
 artikel
369 416 Segregation in Manchester Adult Cystic Fibrosis Centre (MACFC): patients' views on what they need Milnes, J.
 2006
 5 S1 p. S92-
1 p.
 artikel
370 25 SELDI-TOF-MS ProteinChip profiling of serum and nasal cells from Cystic Fibrosis patients Gomes-Alves, P.
 2006
 5 S1 p. S6-
1 p.
 artikel
371 205 Serum biomarkers in CF lung disease Muhlebach, M.S.
 2006
 5 S1 p. S48-
1 p.
 artikel
372 280 Serum phospholipid fatty acid pattern is associated with bone growth in children but not adults with Cystic Fibrosis Gronowitz, E.
 2006
 5 S1 p. S65-
1 p.
 artikel
373 511 Setting up a befriending service for young people with CF MacDonald, K.
 2006
 5 S1 p. S113-
1 p.
 artikel
374 488 Severe and mild CFTR genotypes: age and presenting symptoms in patients diagnosed through newborn screening versus clinical symptoms Munck, A.
 2006
 5 S1 p. S107-
1 p.
 artikel
375 350 Should community physiotherapy be a standard care package with all home intravenous courses? Keane, J.
 2006
 5 S1 p. S77-
1 p.
 artikel
376 358 Shuttle walking test: presentation of a software tool for storing data Lejosne, C.
 2006
 5 S1 p. S79-
1 p.
 artikel
377 389 Social anxiety and inhibition in 10- to 14-year-old youngsters with Cystic Fibrosis: further evidence of resilience? Ulrich, G.
 2006
 5 S1 p. S86-
1 p.
 artikel
378 31 Sodium 4-phenylbutyrate increases CFTR function but also enhances ENaC expression and function in human nasal epithelial cells Prulière-Escabasse, V.
 2006
 5 S1 p. S7-
1 p.
 artikel
379 33 Sodium 4-phenylbutyrate induces IL-8 expression in CF lung epithelial cells through an ERK1/2-dependent pathway Boncoeur, E.
 2006
 5 S1 p. S8-
1 p.
 artikel
380 417 Staff knowledge and understanding of segregation policies in a large adult CF Unit Miller, H.
 2006
 5 S1 p. S93-
1 p.
 artikel
381 388 Stress perception, stress management, and perceived disease impact among 10- to 14-year-old CF youngsters Ullrich, G.
 2006
 5 S1 p. S85-
1 p.
 artikel
382 313 Sun exposure, rather than oral supplements, determines Vitamin D serum levels (VDSL) in cystic fibrosis (CF) Robberecht, E.
 2006
 5 S1 p. S73-
1 p.
 artikel
383 247 Supervising the transition to an alternative enzyme preparation from Pancrease® in one regional adult CF centre Pandya, S.
 2006
 5 S1 p. S57-
1 p.
 artikel
384 167 Surfactant protein D in BAL of children with CF Brazova, J.
 2006
 5 S1 p. S38-
1 p.
 artikel
385 131 Survey of Pseudomonas aeruginosa (PA) genotypes in a regional paediatric shared care CF service Wyatt, H.
 2006
 5 S1 p. S29-
1 p.
 artikel
386 407 Survey on complementary and alternative medicine in French patients with Cystic Fibrosis Agrario, L.
 2006
 5 S1 p. S90-
1 p.
 artikel
387 233 Survival and physical capacity among lung transplanted CF patients in Lund Lannefors, L.
 2006
 5 S1 p. S55-
1 p.
 artikel
388 481 Sweat conductivity measurement with MacroductO coil system for Cystic Fibrosis Cinel, G.
 2006
 5 S1 p. S105-
1 p.
 artikel
389 482 Sweat testing practices in Swiss hospitals Barben, J.
 2006
 5 S1 p. S106-
1 p.
 artikel
390 112 Telithromycin inhibits the production of virulence factors and biofilm formation of P. aeruginosa without affecting its proliferation in vitro Hoffmann, N.
 2006
 5 S1 p. S25-
1 p.
 artikel
391 300 The Cystic Fibrosis food pyramid. How to explain daily nutritional requirements to patients with CF De Rijcke, K.
 2006
 5 S1 p. S70-
1 p.
 artikel
392 369 The Cystic Fibrosis interactive CD-ROM Geddes, C.
 2006
 5 S1 p. S82-
1 p.
 artikel
393 462 The Cystic Fibrosis siblings study Riddle, M.
 2006
 5 S1 p. S101-
1 p.
 artikel
394 497 The determinants of daily physical activity (in steps/day) in Cystic Fibrosis patients: an observational study Kraan, J.
 2006
 5 S1 p. S109-
1 p.
 artikel
395 105 The determination of the synergistic antibiotic combinations for the treatment of multiresistant Pseudomonas aeruginosa isolates from CF patients Sener, B.
 2006
 5 S1 p. S23-
1 p.
 artikel
396 80 The development of an octavalent conjugate P, aeruginosa (Pa) vaccine for Cystic Fibrosis (CF) patients: Results from two Phase II studies Bosse, D.
 2006
 5 S1 p. S18-
1 p.
 artikel
397 385 The development of the Cystic Fibrosis Impact of Diagnosis Scale (CFID) McAleer, R.
 2006
 5 S1 p. S85-
1 p.
 artikel
398 48 The impact of azithromycin on moderately severe adult Cystic Fibrosis patients Hoare, Z.E.K.
 2006
 5 S1 p. S11-
1 p.
 artikel
399 154 The impact of MRSA colonization rates in one adult CF centre Ledson, M.J.
 2006
 5 S1 p. S35-
1 p.
 artikel
400 161 The impact of Scedosporium and Exophiala in sputum samples on the clinical progress of patients with CF Barker, L.
 2006
 5 S1 p. S37-
1 p.
 artikel
401 137 The mobile gene island pKLC102 generates genome diversity of Pseudomonas aeruginosa in CF lungs Würdemann, D.
 2006
 5 S1 p. S31-
1 p.
 artikel
402 366 The Modified Shuttle Test (MST): The development of reference values in adult patients with Cystic Fibrosis Doeleman, W.R.
 2006
 5 S1 p. S81-
1 p.
 artikel
403 260 The natural history of liver disease in Cystic Fibrosis Bhattacharjee, R.
 2006
 5 S1 p. S61-
1 p.
 artikel
404 68 The physiological state of Pseudomonas aeruginosa populations in lungs of Cystic Fibrosis (CF) patients Yang, L.
 2006
 5 S1 p. S15-
1 p.
 artikel
405 169 The presence of proteinase 3 at the plasma membrane after apoptosis decreased the rate of phagocytosis by macrophages: a new pro-inflammatory role of membrane proteinase 3 in CF neutrophils Kantari, C.
 2006
 5 S1 p. S39-
1 p.
 artikel
406 172 The Quorum Sensing system controls the secretion of a cytotoxic activity by Pseudomonas aeruginosa Jensen, P.O.
 2006
 5 S1 p. S39-
1 p.
 artikel
407 279 The retrospective assessment of bone mass density in patients with Cystic Fibrosis Minarowska, A.
 2006
 5 S1 p. S65-
1 p.
 artikel
408 17 The TNFα receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in Cystic Fibrosis Stanke, F.
 2006
 5 S1 p. S5-
1 p.
 artikel
409 40 The trefoil factor TFF3 promotes human airway epithelial differentiation LeSimple, P.
 2006
 5 S1 p. S9-
1 p.
 artikel
410 503 The use of complementary therapies in an Australian Cystic Fibrosis clinic Morton, J.
 2006
 5 S1 p. S111-
1 p.
 artikel
411 351 The value of routinely using the 3-minute step test at annual review Rijnbende, B.
 2006
 5 S1 p. S77-
1 p.
 artikel
412 438 The voice of experience: listening to those who live with Cystic Fibrosis Jessup, M.
 2006
 5 S1 p. S98-
1 p.
 artikel
413 504 Three methods of monitoring adherence in a long-term trial in Cystic Fibrosis Elkins, M.
 2006
 5 S1 p. S111-
1 p.
 artikel
414 153 Timing of bacterial colonization in Cystic Fibrosis with emphasis on Staphylococcus aureus Souza, H.A.P.H.M.
 2006
 5 S1 p. S35-
1 p.
 artikel
415 393 Transition to adulthood for young people with CF Hogan, J.
 2006
 5 S1 p. S87-
1 p.
 artikel
416 513 Travellina with CF — headina for trouble? Stock, D.A.
 2006
 5 S1 p. S113-
1 p.
 artikel
417 102 Treatment of intermittent Pseudomonas aeruginosa colonization with colistin and ciprofloxacin result in very low antibiotic resistance — 15 years follow up Hansen, C.R.
 2006
 5 S1 p. S22-
1 p.
 artikel
418 107 Treatment of multiresistant Gram-negative non-fermentative infections in Cystic Fibrosis patients: more attention required to in vitro studies Ravenni, N.
 2006
 5 S1 p. S24-
1 p.
 artikel
419 242 Treatment with ALTU-135 results in a positive inverse relationship between coefficient of fat absorption with stool weight in subjects with Cystic Fibrosis-related pancreatic insufficiency Borowitz, D.
 2006
 5 S1 p. S56-
1 p.
 artikel
420 267 Treatment with continuous subcutaneous insulin infusion (CSII) pump in Cystic Fibrosis during pregnancy Casciaro, R.
 2006
 5 S1 p. S62-
1 p.
 artikel
421 406 Twelve month review of ward based longline service at regional CF centre Daniels, J.
 2006
 5 S1 p. S90-
1 p.
 artikel
422 256 Two adult patients with Cystic Fibrosis, both lung transplanted, developed acute intestinal intussusseption which revealed a lymphoma Bel Hadj Hassine, A.
 2006
 5 S1 p. S60-
1 p.
 artikel
423 315 Two-year outcomes of behavior and nutrition treatment for young children with Cystic Fibrosis Powers, S.W
 2006
 5 S1 p. S74-
1 p.
 artikel
424 67 Use of anaerobic bacteriological culture for the detection of anaerobic bacteria in sputum from Cystic Fibrosis patients Field, T.R.
 2006
 5 S1 p. S15-
1 p.
 artikel
425 272 Use of continuous subcutaneous glucose monitoring system (CSGMS) in the management of CFRD: the CFRD team and patient perspective Butler, M.
 2006
 5 S1 p. S63-
1 p.
 artikel
426 91 Use of exacerbation score to determine intravenous antibiotic use for acute respiratory exacerbations in Cystic Fibrosis Das, D.
 2006
 5 S1 p. S20-
1 p.
 artikel
427 367 Use of two different equipments of high frequency oral oscillation in cystic fibrosis patients (CFP) Suzan, A.A.B.M.
 2006
 5 S1 p. S81-
1 p.
 artikel
428 356 Utilization of an exercise “Halfway-House” for CF outpatients Morris, A.
 2006
 5 S1 p. S78-
1 p.
 artikel
429 498 Vaccination coverage rates — a challenge for CF centers? Naehrlich, L.
 2006
 5 S1 p. S110-
1 p.
 artikel
430 298 Vitamin D status in one regional adult Cystic Fibrosis centre Pandya, S.
 2006
 5 S1 p. S69-
1 p.
 artikel
431 319 Vitamin K monitoring in adult CF patients Sobanska, A.
 2006
 5 S1 p. S75-
1 p.
 artikel
432 425 What do children with CF know about their illness? Goodhart, F.
 2006
 5 S1 p. S95-
1 p.
 artikel
433 387 When does poor parental adherence with their child's CF care become a child protection issue? Lee, T.W.R.
 2006
 5 S1 p. S85-
1 p.
 artikel
434 59 Whole Body Vibration — a new therapeutic approach to improve muscle function in CF? van Koningsbruggen, S.
 2006
 5 S1 p. S14-
1 p.
 artikel
435 430 Work disability in adults with Cystic Fibrosis and its relationship to quality of life Braithwaite, M.
 2006
 5 S1 p. S96-
1 p.
 artikel
436 212 Working capacity and lung function in physically active patients with Cystic Fibrosis were unchanged after 6 months of training Sahlberg, M.
 2006
 5 S1 p. S49-
1 p.
 artikel
437 352 Working in partnership with families to openly monitor aerosol therapy with an in-device data logger McCormack, R.
 2006
 5 S1 p. S77-
1 p.
 artikel
                             437 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland